Considering the use of animal models in drug development
Drug Discovery World
AUGUST 13, 2024
They are assumed to closely mimic human disease progression and act as a good testing ground for toxicology studies and pharmacokinetics 1. A lack of translatability The most obvious argument against the continued blanket requirement for AMs is that they are not very translational for many disease areas. Possibly not.
Let's personalize your content